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http:WHAT THIS PAPER ADDS
There is no universally accepted aortic graft infection case deﬁnition and clinical approaches to this complex
condition differ widely with variable outcomes. Here, the Management of Aortic Graft Infection Collaboration
(MAGIC), involving clinicians from several English hospital National Health Service Trusts with large vascular
services, propose a formal case deﬁnition, derived by a process of multidisciplinary, expert consensus. The
deﬁnition is readily applied in routine practice and aids early recognition. Importantly and towards development
of evidence-based clinical guidelines that are presently lacking, it provides a consistent diagnostic standard,
essential for clinical trial design and meaningful comparison between diagnostic and therapeutic strategies.Objective/Background: The management of aortic graft infection (AGI) is highly complex and in the absence of a
universally accepted case deﬁnition and evidence-based guidelines, clinical approaches and outcomes vary
widely. The objective was to deﬁne precise criteria for diagnosing AGI.
Methods: A process of expert review and consensus, involving formal collaboration between vascular surgeons,
infection specialists, and radiologists from several English National Health Service hospital Trusts with large
vascular services (Management of Aortic Graft Infection Collaboration [MAGIC]), produced the deﬁnition.
Results: Diagnostic criteria from three categories were classiﬁed asmajor orminor. It is proposed that AGI should be
suspected if a singlemajor criterionor twoormoreminorcriteria fromdifferentcategories arepresent.AGI is diagnosed if
there is onemajor plus any criterion (major orminor) from another category. (i) Clinical/surgicalmajor criteria comprise
intraoperative identiﬁcation of pus around a graft and situations where direct communication between the prosthesis
and a nonsterile site exists, including ﬁstulae, exposed grafts in openwounds, and deployment of an endovascular stent-
graft into an infected ﬁeld (e.g.,mycotic aneurysm);minor criteria are localized AGI features or fever38C,whereAGI is
the most likely cause. (ii) Radiologicalmajor criteria comprise increasing perigraft gas volume on serial computed
tomography (CT) imaging or perigraft gas or ﬂuid (7 weeks and 3 months, respectively) postimplantation; minor
criteria includeotherCT features orevidence fromalternative imaging techniques. (iii) Laboratorymajor criteria comprise
isolation of microorganisms from percutaneous aspirates of perigraft ﬂuid, explanted grafts, and other intraoperative
specimens;minor criteria are positive blood cultures or elevated inﬂammatory indices with no alternative source.responding author. Department of Infectious Diseases, St Thomas’ Hospital, Westminster Bridge Rd, London SE1 7EH, UK.
il address: Nicholas.Price@gstt.nhs.uk (N.M. Price).
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759Conclusion: This AGI deﬁnition potentially offers a practical and consistentdiagnostic standard, essential for comparing
clinical management strategies, trial design, and developing evidence-based guidelines. It requires validation that is
planned in a multicenter, clinical service database supported by the Vascular Society of Great Britain & Ireland.
 2016 TheAuthors. Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.This is an open access
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Vascular prostheses (grafts placed at open surgery, and
endovascular stent-grafts inserted via “keyhole” techniques)
are increasingly used to treat life-threatening aortic aneu-
rysms, aortic dissection, and occlusive vascular disease.
Device insertion is complicated by infection in 0.5e4% of
cases, causing major morbidity, mortality, and economic
cost.1e4 Fundamental tenets of aortic graft infection (AGI)
management are removal of the infected device, revascu-
larization (either by an anatomic route, or an uninfected
extra-anatomic route), and adjunctive antimicrobial ther-
apy.5 However, vascular prostheses are not designed for
ease of removal and in the setting of infection, surgical
explantation carries a mortality of 18e30%.6e10 Conversely,
and often despite prolonged antimicrobial treatment,
mortality within 2 years can approach 100% if an infected
endograft is left in situ.6,11
The diagnosis and management of AGI is highly complex,
clinical manifestations are protean, and there is no “gold-
standard” diagnostic test.3,5 In the existing literature,
radiological data are mostly descriptive, microbiology de-
tails are brief or incomplete, and there have been no well
designed trials of the optimum antimicrobial agent(s), route
of administration, and treatment duration.5 The better
surgical studies are mostly large case series and there are
no randomized, controlled trials of surgical strategies. It is
therefore unsurprising that, in contrast to the well-
established evidence-based guidelines for managing in-
fections of other surgical prostheses (e.g., joints, heart
valves), these are lacking for AGI.3
Addressing this deﬁciency requires a standardized case
deﬁnition. Although there is general consensus that AGI is
diagnosed by a combination of clinical, radiological, and
laboratory ﬁndings, where described in the methodology of
a very small number of publications, diagnostic criteria lack
precision and do not give sufﬁcient “weight” to the most
signiﬁcant.5,12,13 It is also important that any deﬁnition is
useful in routine clinical practice, for example in situations
where an infected device cannot be explanted and conﬁr-
matory microbiology is lacking. Here, criteria used to
diagnose AGI are reviewed by an experienced, multidisci-
plinary group of clinicians and a formal case deﬁnition is
derived by expert consensus.METHODS
The Management of Aortic Graft Infection Collaboration
(MAGIC) was established in 2013 and comprises vascular
surgeons, infectious diseases physicians, microbiologists,
and radiologists experienced in the management of AGI,from several English National Health Service (NHS) Trusts
with substantial vascular services (Guy’s & St Thomas’ NHS
Foundation Trust, Heart of England NHS Foundation Trust,
Leeds Teaching Hospitals NHS Trust, Royal Free London NHS
Foundation Trust, and University Hospital South Man-
chester NHS Foundation Trust). The AGI case deﬁnition was
primarily developed for the MAGIC clinical service evalua-
tion database (supported by the Vascular Society of Great
Britain & Ireland) by expert consensus and informed by a
systematic literature review. A modiﬁed Delphi method was
used in the planning and development process.14 Individual
members initially proposed diagnostic criteria for wider
group discussion and review. Independent feedback and
comments were then collated and potential criteria (and
their precise deﬁnitions) were included, modiﬁed, or
excluded by an iterative process. Retained criteria were also
ranked as either “major” or “minor”, depending upon the
weight of opinion/evidence that they were considered to
contribute towards making a deﬁnitive diagnosis of AGI.
Consensus was reached following formally convened face-
to-face group meetings, teleconferences, and e-mail com-
munications (N.M.P. was chairperson).
Results of a systematic review of English-language pub-
lications between 1 January 2005 and 22 June 2016
informed the consensus process. (This was speciﬁcally
undertaken for a separate but closely related project
involving several of the authors: J.A.T.S., R.E.B. and N.M.P.
comprise an ongoing management of vascular graft infec-
tion guidelines working party, representing the British So-
ciety of Antimicrobial Chemotherapy, the Vascular Society
of Great Britain & Ireland, and MAGIC, respectively.) Data-
base search terms and objectives included diagnostic fac-
tors required to deﬁne vascular graft infection. Details of
the methodology and results are registered on the PROS-
PERO international prospective register of systematic re-
views [“Diagnosis and management of vascular graft
infection (VGI)”, available at; http://www.crd.york.ac.uk/
PROSPERO/display_record.asp?ID¼CRD42016038759].
O.T.L. and N.M.P. produced the ﬁrst draft of themanuscript
and made subsequent revisions. The ﬁnalized MAGIC
consensus was also presented at a national conference on 1
April 2016 (Guy’s & St Thomas’ Aortic Graft Infection
Symposium).RESULTS
Diagnostic criteria were divided into three categories rep-
resenting the key specialties that must work closely
together in order to optimize clinical management of AGI
cases and reﬂecting the composition of the expert group.
Figure 1. Aortic graft infection (AGI) is suspected in a patient with any isolated major criterion, or minor criteria from two of the three
categories: clinical/surgical, radiological, or laboratory. AGI is diagnosed in the presence of a single major criterion, plus any other criterion
(major or minor) from another category. Note. Where microbiological investigations identify potential “contaminant” organisms (e.g.,
coagulase-negative staphylococci, propionibacteria, corynebacteria, and other skin commensals) a minimum of (i) two intraoperative
specimens, (ii) two blood cultures, or (iii) one intraoperative specimen plus one blood culture must be positive with an indistinguishable
organism in each sample based on antibiograms or a recognized typing method, e.g. pulsed-ﬁeld electrophoresis. CT ¼ computed to-
mography; FDG ¼ ﬂuorodeoxyglucose; PET ¼ positron emission tomography; ESR ¼ erythrocyte sedimentation rate; CRP ¼ C-reactive
protein.
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“minor” within each category. Fig. 1 shows a summary of
the results. AGI is suspected in a patient with any isolated
major criterion, or minor criteria from two of the three
categories: clinical/surgical, radiological or laboratory. AGI is
diagnosed in the presence of a single major criterion, plus
any other criterion (major or minor) from another category.
Clinical/surgical criteria
The problems posed by the nonspeciﬁc nature of the many
clinical manifestations of AGI were discussed. Although
often absent, localized clinical features of AGI may simply
represent postoperative wound inﬂammation or superﬁcial
soft tissue infection rather than graft involvement per se.
Lack of speciﬁcity was also considered problematic with
fever 38C and it was therefore included with the addi-
tional caveat of a requirement for no other clinically
apparent focus of infection. Both were consequently
designated minor diagnostic criteria, but others proposed
were not retained following discussion. In particular, sys-
temic clinical features of sepsis (e.g., “septic shock”) may
result from any bloodstream infection, irrespective of
whether or not AGI is the primary focus. Furthermore,
determination of “systemic inﬂammatory response syn-
drome” relies upon the presence of other minor/nonspeciﬁc
criteria (e.g., elevated blood white cells and fever 38C).15
Although anorexia, weight loss, lethargy, and malaise arecommon manifestations of AGI, they were also considered
insufﬁciently speciﬁc for inclusion
The ﬁnding of visible intraoperative “pus” directly around
a graft was initially proposed as convincing evidence of
infection, but, following discussion, it was acknowledged
that ﬂuid with a similar “cloudy” appearance might be
present for noninfective reasons, particularly if subsequent
cultures prove to be negative. This major criterion was
therefore modiﬁed to include the demonstration of pus
cells by direct microscopy. Although an additional burden
on the laboratory, microscopy is simple to perform and
provides objectivity. In addition, it was agreed that AGI can
also be strongly inferred if there is direct communication
between a nonsterile site and the vascular prosthesis itself,
including the following situations: ﬁstulae (e.g., aortoenteric
or aortobronchial), exposed grafts in deep open wounds,
and deployment of an endovascular stent-graft into an
already infected ﬁeld (e.g., mycotic aneurysm).
Radiological criteria
In general, computed tomography (CT) was considered the
ﬁrst-choice imaging modality and the standard that others
are compared against. Gas-forming organisms resulting in
perigraft gas formation and rapid expansion of the aneu-
rysm sac on serial scans was considered major evidence of
AGI, but the principal limitation in routine practice is
differentiating typical postoperative appearances from
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when does normal become abnormal? Unfortunately,
exactly at what point in time after surgery the presence of
perigraft gas or ﬂuid is suspicious of AGI has been impre-
cisely deﬁned in the literature. Reports are also without
reference to a diagnostic standard and do not include
speciﬁcity/sensitivity data. Noting these limitations, peri-
graft gas is rare beyond 1 week after surgery but appears to
indicate AGI after 4e7 weeks.16,17 Similarly, persistent
perigraft ﬂuid up to 3 months after surgery is not atypical
but highly suspicious thereafter.16 It was concluded that CT-
guided aspiration of perigraft ﬂuid for microbiological
analysis should be undertaken in this situation but thera-
peutic placement of drains generally avoided in order to
avoid introducing infection.18e20
Radiological ﬁndings that were considered to be minor
criteria, requiring other evidence of AGI because of their
subjective nature, include descriptions of perigraft soft tis-
sue abnormalities such as “phlegmon” (an ill-deﬁned in-
ﬂammatory mass without overt abscess formation) and
“stranding” (abnormally increased fat attenuation).21e23
Secondary involvement by contiguous spread of infection
involving adjacent structures may also, for example, cause
hydronephrosis, focal bowel wall thickening, psoas abscess,
and vertebral osteomyelitis/discitis but require the pres-
ence of major features to conclude AGI deﬁnitively.18,22
Although a well-recognized feature of AGI, pseudoaneur-
ysms may also occur for noninfective reasons such as
dehiscence of a suture line. Finally, AGI is unlikely to be
confused with primary large vessel vasculitis, which is rare
in comparison, not typically localized to the region around a
stent-graft, and associated with uniform mural thickening
that is not characteristic of infection.24
With regard to the utility of other imaging techniques,
magnetic resonance imaging has not been evaluated as
extensively as CT but may be more sensitive in detection of
inﬂammatory changes (e.g., in the psoas muscle) and can
distinguish hematoma from perigraft ﬂuid.18,25 The sensi-
tivity of technetium-99m/indium-111-labeled leukocyte
imaging has been suggested to approach 100%, but false
positivity is an issue and CT (or single-photon emission CT/
CT if available) is usually required to delineate the signiﬁ-
cance of abnormal uptake consistent with focal infection/
inﬂammation.18,25,26 18F-ﬂuorodeoxyglucose positron emis-
sion tomography (PET)/CT shows promise, but careful
interpretation is required as prosthetic grafts can also
provoke chronic low-grade inﬂammation for several years
after surgery with associated diffuse tracer uptake.27 The
pattern of tracer uptake (focal as opposed to diffuse)
together with ancillary ﬁndings on the CT component of the
PET can improve diagnostic accuracy.28e30Laboratory criteria
Culture of microorganisms from surgically explanted grafts
or other intraoperative specimens (e.g., pus, tissue) was
considered to be robust evidence of infection and therefore
a major diagnostic criterion. Similarly, as a percutaneousaspirate of perigraft ﬂuid/pus using radiological guidance
entails an aseptic technique that minimizes contamination,
positive microbiology from such samples is highly sugges-
tive of AGI. Where standard laboratory culture is negative,
for example, owing to the fastidious nature of the organism
or prior antibiotic use, highly sensitive molecular techniques
(e.g., “broad range” polymerase chain reaction to identify
microbial DNA) were considered to have signiﬁcant diag-
nostic value. There was insufﬁcient data and experience to
comment on other nonculture advancements in microbio-
logical diagnosis, for example matrix-assisted laser desorp-
tion/ionization time-of-ﬂight (MALDI-TOF).
Compared with high-virulence pathogens that would
rarely be regarded as clinically insigniﬁcant (e.g., Staphylo-
coccus aureus), isolation of possible contaminant organisms
(e.g., skin ﬂora, including Staphylococcus epidermidis, Pro-
pionibacterium spp. etc.) was felt to require additional
levels of stringency in order to interpret their true signiﬁ-
cance. For a robust diagnosis, it is proposed that at least
two samples (blood cultures and/or intraoperative speci-
mens) must be positive with an indistinguishable organism
in each (e.g., based on the antibiogram or a recognized
typing method such as pulse-ﬁeld electrophoresis).
While blood cultures may be negative in more than half
of AGI cases, repeated isolation of the same organism in
multiple samples is a classic feature of an endovascular
infection.5,11 In contrast to other microbiological diagnostic
criteria, positive blood cultures were considered minor
criteria as they do not provide direct, site-speciﬁc evidence
of AGI, and their signiﬁcance depends upon how conﬁdently
alternative sources can be excluded. The use of blood in-
ﬂammatory markers as corroborative evidence for AGI was
proposed, but these were also classed as minor criteria
because they are nonspeciﬁc and typically elevated in the
immediate postoperative period and multiple other con-
current, noninfective conditions. In contrast, it was felt that
the diagnosis of AGI is questionable if inﬂammatory indices
are completely normal.DISCUSSION
AGI is an extremely complex clinical challenge and likely to
be encountered more frequently in the future. Mortality
from AGI is high, and diagnostic and treatment approaches
differ signiﬁcantly from center to center, with variable
outcomes at present. Unfortunately the production of
clinical guidelines is hampered by the lack of an agreed case
deﬁnition, which is essential for designing high-quality
clinical trials and evaluating evidence from research
studies. A paucity of eligible publications in a systematic
literature review justiﬁes an approach based upon expert
consensus at the present time. This is the ﬁrst report pro-
posing a deﬁnition of AGI, involving a formal, multidisci-
plinary, consensus process.
It has been postulated that the diverse range of path-
ogens causing AGI divide into two groups, which are
dependent upon the nature of the clinical presentation
and time elapsed since graft insertion.5,31 “Early”
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duced at the time of surgery (e.g., S. aureus) and tend to
produce an abrupt-onset, more toxic clinical picture with
high fever. In comparison, “late” infection (>4 months)
typically runs a more mild, subtle, and chronic course,
reﬂecting the more indolent nature of the pathogens
involved (e.g., skin ﬂora). In reality, the distinction is much
less clear cut and other factors are also important, for
example AGI with aortoenteric ﬁstulae are frequently
polymicrobial owing to involvement of gut commensals
including anaerobes and fungi. Although no pathogen is
identiﬁed in many cases, there are some parallels that
might be helpfully extrapolated from prosthetic joint
infection where multidisciplinary collaboration has pro-
duced universally accepted diagnostic standards and
management algorithms over the last decade.32 Standard
practice is to obtain at least three, and optimally 5e6,
intraoperative samples in order to improve the diagnostic
yield and help determine the signiﬁcance of possible
“contaminant” organisms. In addition sonication has been
used to improve isolation of pathogens from explanted
joint prostheses by disruption of bacterial bioﬁlm, but its
beneﬁt remains unknown in AGI.
Potential limitations are acknowledged with some minor
criteria necessitating an unavoidable degree of subjective
judgment. Speciﬁcally, these include the interpretation of
certain imaging (e.g., perigraft “stranding”, rapid aneurysm
expansion, increased metabolic activity on FDG-PET/CT or
radiolabelled white cell accumulation) and those requiring
that causes other than AGI be excluded (i.e., raised in-
ﬂammatory indices, fever, localized clinical features, and
positive blood cultures). Further validation of these criteria
is needed but in particular it is worth noting that the
Centers for Disease Control central venous device infection
deﬁnition also entails a similar process of eliminating
alternative sources for positive blood cultures.33 Moreover
it has also been proposed that any bacteremia, irrespective
of source and within 4 weeks of graft implantation, should
automatically be regarded with suspicion owing to the
likelihood of hematogenous “seeding” to the prosthetic
luminal surface before endothelial coverage is presumed to
have occurred.5
Notwithstanding signiﬁcant deﬁciencies in the published
evidence and in order to deﬁne a necessary time point “cut-
off”, the recommendation that AGI should be strongly
suspected if CT demonstrates perigraft ﬂuid at 3 months
post-graft insertion was considered reasonable and consis-
tent with clinical experience.18 This criterion is not 100%
speciﬁc as ﬂuid has very exceptionally been reported at 1
year without AGI,19 but such limitations highlight the
importance of no single feature being diagnostic and the
requirement for corroborative evidence from other cate-
gories to fulﬁll the deﬁnition. Although not universally
available, research is currently underway to determine the
utility of 18F-FDG-PET/CT, which has signiﬁcant potential in
improving diagnosis of AGI and monitoring response to
treatment.27e29In addition to comparing the range of diagnostic and
treatment approaches employed by several English NHS
vascular services in the management of AGI, the proposed
case deﬁnition will be examined in a forthcoming multi-
center service evaluation database, supported by the
Vascular Society of Great Britain & Ireland. The intention is
to invite wider participation from other vascular services
upon completion of the ﬁve-center pilot project, and
further aims include development of audit standards, best
practice guidelines, and identiﬁcation of key questions for
future research studies. Finally, the creation of a national
AGI registry is an important next step forward in improving
patient management but requires a robust AGI deﬁnition to
determine eligible cases for entry.34CONFLICT OF INTEREST
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